We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microfluidic Device Rapidly Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 23 Aug 2015
A polymeric centrifugal microfluidic platform has been developed for the rapid and sensitive identification of bacteria directly from urine, thus eliminating time-consuming cultivation steps.

Untreated urinary tract infections can quickly move to a life-threatening condition and cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.

Scientists at the Jena University Hospital (Germany) have created a Lab-on-a-Disc platform that combines microfluidics and Raman microscopy, a modern optical detection method. More...
The platform utilizes the rotationally induced centrifugal field to efficiently capture bacteria directly from suspension within a glass-polymer hybrid chip. Once trapped in an array of small V-shaped structures, the bacteria are readily available for spectroscopic characterization, such as Raman spectroscopic fingerprinting, providing valuable information on the characteristics of the captured bacteria.

Anonymized urine samples were provided by the hospital’s Institute of Medical Microbiology. They originated from different patients with single pathogen urinary tract infections (UTIs) of Enterococcus faecalis and Escherichia coli. To remove bigger particles such as leukocytes or epithelial cells, the urine samples were run through membrane filters, centrifuged, the pellet washed twice with phosphate buffered saline (PBS), and is finally re-suspended in PBS before being loaded into the device. A CRM 300 micro-Raman setup (WITec, Ulm, Germany), equipped with a 600 lines/mm grating was used for micro-Raman measurements.

The whole procedure, including sample preparation, requires about one hour to obtain a valuable result, marking a significant reduction in diagnosis time when compared to the 24 hours and more, typically required for standard microbiological methods. Characterization of the captured bacteria by label-free conventional micro-Raman spectroscopy allows rapid identification of the pathogens with their characteristic features, which is valuable for first screening analysis. The device has been easily adapted for fluorescence measurements, paving the way for the development of microfluidics-based immunochemical assays, illustrating a high potential of the device for numerous applications in spectroscopy-based point-of-care diagnostics.

Ulrich-Christian Schröder, a doctoral student and lead author of the study said, “Our device works by loading a few microliters of a patient's urine sample into a tiny chip, which is then rotated with a high angular velocity so that any bacteria is guided by centrifugal force through microfluidic channels to a small chamber where 'V-cup capture units' collect it for optical investigation. We were able to identify Escherichia coli and Enterococcus faecalis within 70 minutes, directly from patients' urine samples.” The study was published on August 11, 2015, in the journal Biomicrofluidics.

Related Links:

Jena University Hospital
WITec 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.